About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,782 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,782 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2461-2480 of 4,782 trials

RecruitingSafety and Efficacy of BA1302 in Patients With Advanced Solid TumorsThis is a first-in-human (FIH), multicenter, open-label Phase I study to evaluate the safety, tolerability, PK profile, immunogenicity, and preliminary efficacy of BA1302 in…NCT06596915·Beijing Enrolling by invitationDevelopment & Clinical Application of K-PaC Registry Version 2.0Development and clinical use of pancreatic cancer registry * Development of K-PaC Registry v.2.0: Retrospective data integration from 2010 to 2022 and prospective data collection…NCT07171515·Goyang, Gyeonggido CompletedPreoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas.In our multicenter retrospective study, preoperative CA 19.9 levels predicts the presence of lymph node metastasis at final histology in patients underwent pancreatoduodenectomy…NCT05959213 UnknownAdjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph NodesAdjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes after curative resection.NCT02754180·Beijing RecruitingGemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic CancerThis phase II trial tests how well gemcitabine, cisplatin and nab-paclitaxel given before surgery (neoadjuvant) works in treating patients with pancreatic cancer that can be…NCT06423326·Washington D.C., District of Columbia and 1 other

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

CompletedGene Therapy in Treating Patients With CancerRATIONALE: Inserting a gene that has been created in the laboratory into a person's white blood cells may make the body build an immune response to kill cancer cells.NCT00004178·Boston, Massachusetts

TerminatedTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsThis phase Ib trial studies the best way of TLR8 Agonist VTX-2337 and cyclophosphamide in treating patients with a solid tumor that has spread from the primary site (place where…NCT02650635·Scottsdale, Arizona

CompletedTrial of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaOpen-label, dose-escalating, Phase IIa trial of NanoPac® to treat subjects with locally advanced pancreatic adenocarcinoma via direct intratumoral injection.NCT03077685·Los Angeles, California and 3 others

CompletedCapecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00983268·Nashville, Tennessee

UnknownClinical Study of Pan-cancer DNA Methylation Test in PlasmaWe intend to establish an efficient method for plasma cfDNA extraction and Bisulfite transformation to facilitate the detection of DNA methylation status using multiplex…NCT05685524·Zhengzhou, Henan

CompletedA New Prognostic Score Model for Pancreatic Ductal AdenocarcinomaThe AJCC TNM staging system is the prevailing method in prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC) at present , but it did not include factors such as the…NCT05547074·Hangzhou, Zhejiang

CompletedAcceptability of Less Harmful Alternatives to CigarettesRATIONALE: A study that evaluates participants' beliefs about smokeless tobacco products and nicotine replacement therapy may be useful in helping smokers stop smoking.NCT00957424·Buffalo, New York

CompletedYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerRATIONALE: Radiolabeled drugs such as yttrium Y 90 SMT 487 can locate tumor cells and deliver tumor-killing substances to them without harming normal cells.NCT00006368·Tampa, Florida

Temporarily not availableContinued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)The EF-54 program (PANOVA-3CA) is a continued access program for adults with locally advanced pancreatic cancer to access TTFields therapy in combination with gemcitabine and…NCT07319910

UnknownCombination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic CancerThe objective of this study is to evaluate the efficacy and safety of radiation therapy combined with anti-PD-1 antibody in patients with pancreatic cancerNCT03374293·Hangzhou, Zhejiang

RecruitingA Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.The purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.NCT07157033·Duarte, California and 4 others

WithdrawnPreoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the LiverDoctors and researchers leading this study hope to learn more about peptide receptor radionuclide therapy (PRRT) in combination with cytoreduction (surgically removing tumors).NCT05610826·Chicago, Illinois

CompletedAZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryRATIONALE: AZD0530 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00265876·Vancouver, British Columbia and 3 others

RecruitingJAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS AlterationThis study is to evaluate the safety and tolerability of pan-KRAS inhibitor JAB-23E73 Monotherapy and in Combination with Other Agents in adult participants with advanced solid…NCT06973564·Rochester, Minnesota and 3 others

TerminatedClinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic CancerDetermine the overall response rate (ORR) of bemcentinib plus chemotherapy (nab-paclitaxel/gemcitabine) in patients with metastatic pancreatic adenocarcinoma.NCT03649321·Dallas, Texas

PreviousPage 124 of 240Next